Groowe Groowe / Newsroom / ALGS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ALGS News

Aligos Therapeutics, Inc. Common Stock

Form 8-K

sec.gov
ALGS

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results

globenewswire.com
ALGS

Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026

globenewswire.com
ALGS

Non-Alcoholic Steatohepatitis (NASH/MASH) - Drug Pipeline Insight 2026 | 75+ Candidates Across 70+ Companies Drive Licensing and Investment Opportunities

globenewswire.com
NVO VKTX GSK ALGS

Remix Therapeutics™ Appoints Michael Landsittel to Board of Directors

globenewswire.com
ALGS

Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026

globenewswire.com
ALGS

Form 8-K

sec.gov
ALGS

Aligos Therapeutics to Present at the Cantor Global Healthcare Conference

globenewswire.com
ALGS

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

globenewswire.com
ALGS

Form 8-K

sec.gov
ALGS